Manzo Pharmaceuticals, Inc. (MNZO)

Market Cap	1.10K
Revenue (ttm)	n/a
Net Income (ttm)	7.75M
Shares Out	1.10B
EPS (ttm)	1.91
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	98,822
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-109.46
RSI	41.42
Earnings Date	n/a

About Manzo Pharmaceuticals

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporat...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1980
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: MNZO

Financial Performance

In 2004, Manzo Pharmaceuticals's revenue was $3.07 million, an increase of 2.22% compared to the previous year's $3.00 million. Losses were -$4.15 million, 4.99% more than in 2003.